Eyevance Pharmaceuticals

Australia’s PolyActiva Opens Fort Worth Office With New Locally Based CEO, CFO, and CSO

by | Jul 17, 2025
After selling Fort Worth-based Eyevance Pharmaceuticals for $225 million in 2020, Jerry St. Peter is back in the company-building business—now as CEO of Melbourne-based PolyActiva. He’s bringing his former top team with him as the company ramps up U.S. clinical trials of its glaucoma treatment.
MORE
Startups Are the Key to Fort Worth’s Economic Recovery, New HSC Report Shows
by | Nov 17, 2020
New research funded by HSC and released by Sparkyard shows that startups created 155,307 new jobs in Tarrant County from 2013 to 2018.
MORE
13 Companies and Organizations Spawned by Alcon Alumni
by | Jan 22, 2020
Here are notable organizations that veterans of the eye care giant have started or hold executive positions in.
MORE
funding acquired
Follow the Money: Actuate Raises $3.9M, TPG Closes $14B in Funds; Sabre Acquires Radixx
by | Oct 17, 2019
In this weekly roundup of funding, merger, and acquisition activity involving companies and investors with ties to North Texas, you’ll also find news from Solovis, Traveller Capital, SSE Holdco, Sanara MedTech, Bios Partners, Mark Cuban, Nebula Healthcare, HMS Holdings, The Living Company, Sun Holdings, BBG, and Eyevance Pharmaceuticals.
MORE